These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Commentary: how the doctor can counter commercial bias in the dissemination of pharmacotherapeutic knowledge. Carpenter WT J Nerv Ment Dis; 2002 Sep; 190(9):593-6. PubMed ID: 12357092 [No Abstract] [Full Text] [Related]
3. Pharmacogenomics: the promise of personalized medicine. Hood E Environ Health Perspect; 2003 Aug; 111(11):A581-9. PubMed ID: 12928155 [No Abstract] [Full Text] [Related]
4. Old drugs, new bottles, therapeutic advantage? Somberg JC Am J Ther; 2002; 9(4):273-4. PubMed ID: 12115014 [No Abstract] [Full Text] [Related]
5. Pharmaceutical industry overview: optimal drug therapy. Blake P Can J Clin Pharmacol; 2001; 8 Suppl A():48A-52A. PubMed ID: 11586380 [TBL] [Abstract][Full Text] [Related]
6. NCCN Oncology Risk Evaluation and Mitigation Strategies White Paper: Recommendations for Stakeholders. Johnson PE; Dahlman G; Eng K; Garg R; Gottlieb S; Hoffman JM; Howell P; Jahanzeb M; Johnson S; Mackler E; Rubino M; Sarokhan B; Marc Stewart F; Tyler T; Vose JM; Weinstein S; Li EC; Demartino J; J Natl Compr Canc Netw; 2010 Sep; 8 Suppl 7():S7-S27. PubMed ID: 20947724 [TBL] [Abstract][Full Text] [Related]
7. Prescribing organizational change--what works for whom? Locock L; Bucknall T; Titler MG Worldviews Evid Based Nurs; 2004; 1(4):203-5. PubMed ID: 17166147 [No Abstract] [Full Text] [Related]
9. Meeting the challenges of drug discovery: a multidisciplinary re-evaluation of current practices. Keystone Symposium 'Meeting the Challenges of Drug Discovery', Vancouver, Canada, 15-19 January 2005. Burley SK; Park F Genome Biol; 2005; 6(7):330. PubMed ID: 15998459 [TBL] [Abstract][Full Text] [Related]
10. [Drug development--from receptor research to therapy]. Lammintausta R; Scheinin M Duodecim; 1998; 114(10):957-66. PubMed ID: 11524784 [No Abstract] [Full Text] [Related]
11. Medical innovation at the crossroads. Laubach GD; Gelijns AC Issues Sci Technol; 1995; 11(3):33-40. PubMed ID: 10141894 [No Abstract] [Full Text] [Related]
13. [Critical reflections on innovation, therapeutic progress and economics of health]. Bouvenot G Therapie; 2001; 56(2):103-6. PubMed ID: 11471359 [TBL] [Abstract][Full Text] [Related]
14. Proceedings of the plenary sessions of the 19th International Congress of Chemotherapy. Montreal, Canada, July 16-21, 1995. Am J Med; 1995 Dec; 99(6A):1S-92S. PubMed ID: 8585527 [No Abstract] [Full Text] [Related]
15. Pharmacogenetics: development issues and solutions for safe and effective medicines. Arnold HP; McHale D Pharmacogenomics; 2006 Mar; 7(2):149-55. PubMed ID: 16515393 [No Abstract] [Full Text] [Related]
17. DNA 50 years on: has it helped drug discovery? Higgs G Lancet; 2003 Apr; 361(9366):1394. PubMed ID: 12711506 [No Abstract] [Full Text] [Related]
18. Innovation in biotechnology: current and future states. Woollett GR Clin Pharmacol Ther; 2012 Jan; 91(1):17-20. PubMed ID: 22179626 [TBL] [Abstract][Full Text] [Related]
19. [Biopharmaceutical industry's commitment to innovation and to the future of health care]. Marini G Recenti Prog Med; 2006 Nov; 97(11):626-33. PubMed ID: 17252719 [TBL] [Abstract][Full Text] [Related]
20. [What is a real therapeutic advance]. Assist Inferm Ric; 2002; 21(3):152-60. PubMed ID: 12593081 [No Abstract] [Full Text] [Related] [Next] [New Search]